| Medicine/Year | 2009 | 2010 | 2011 | 2012 | 2013 |
| Follitropinalfa | |||||
| N of women | 11 | 1 | 0 | 25 | 66 |
| Average dose in IU (SD) | 3454.55 IU (SD 1203.31) | 2900 (SD 0) | 1171 (SD 314.16) | 1643.9 (SD 465.3) | |
| Follitropin beta IU | |||||
| N of women | 111 | 154 | 25 | 9 | 33 |
| Average dose in IU (SD) | 1862.55 (SD 660.94) | 1643.95 (SD 441) | 1634 (SD 423.5) | 1388.9 (SD 645.68) | 23.4 (SD 8.8) |
| Urofollitropin 75 IU amp | |||||
| N of women | 5 | 29 | 63 | 113 | 78 |
| Average dose in amp (SD) | 13 (SD 4.4) | 18.8 (SD 7.4) | 21.3 (SD 7.37) | 24.21 (SD 10.23) | 23.4 (SD 8.8) |
| urFSH + urLH 75 IU:75 IU | |||||
| N of women | 42 | 75 | 69 | 90 | 77 |
| Average dose in amp (SD) | 13.93 (SD 7.38) | 13.5 (SD 8.84) | 25.55 (SD 16.07) | 26.55 (SD 17.98) | 3.75 (SD 24.1) |
| cetrorelix amp 0.25 mg | |||||
| N of women | 4 | 71 | 102 | 10 | 126 |
| Average dose in mg (SD) | 3.75 (SD 1.63) | 4.61 (SD 1.65) | 3.84 (SD 1.32) | 3.79 (SD 1.3) | 4.9 (SD 1.9) |
| ganirelix amp 0.25 mg | |||||
| N of women | 116 | 57 | 0 | 0 | 0 |
| Average dose in mg (SD) | 3.35 (SD 1.17) | 4.01 (SD 1.32) | |||
| Human chorion gonadotropin | |||||
| N of women | 119 | 177 | 103 | 136 | 125 |
| Average dose in IU (SD) | 7231.09 (SD 1634.42) | 6963.06 (SD 1038.8) | 6752.52 (SD 1216.23) | 7088.23 (SD 1056.22) | 6660 (SD 1109.4) |
| Nafarelin mcg/ml | |||||
| N of women | 0 | 8 | 0 | 0 | 0 |
| Average dose in mcg (SD) | 17,700 (SD 10725) | ||||
| triptorelin 0.1 mg amp | |||||
| N of women | 1 | 38 | 4 | 17 | 3 |
| Average dose in amp (SD) | 2 | 10.26 (SD 2.55) | 5.5 (SD 3.25) | 4.9 (SD 2.6) | 11.7 (SD 11.6) |
| clomiphen 50 mg/tb | |||||
| N of women | 7 | 6 | 0 | 5 | 1 |
| Average dose in tb (SD) | 11.14 (SD 2.20) | 7.5 (SD 2.5) | 8 (SD 2.4) | 5 (SD 0) | |
| letrozole 2.5 mg/tb | |||||
| N of women | 4 | 8 | 1 | 0 | 0 |
| Average dose in tb (SD) | 8.5 (SD 3.5) | 8.13 (SD 2.34) | 10 (SD 0) | ||